Markku Lähteenvuo

Niuvanniemi Hospital

Finland

Research Interests

Explore related searches

Professors in Finland

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

Articles (20)

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2024

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2022

Year:

2022

Year:

2022

Year:

2022

Collaborators (11)

Minna Holm

Finnish Institute for Health and Welfare

FINLAND

View details

Seena Fazel

University of Oxford

UNITED KINGDOM

View details

Mari Kaunisto

University of Helsinki

FINLAND

View details

Erkki Isometsä

University of Helsinki

FINLAND

View details

Annamari Tuulio-Henriksson

University of Helsinki

FINLAND

View details

Aarno Palotie

University of Helsinki

FINLAND

View details

Kimmo Suokas

University of Tampere

FINLAND

View details

Ari Ahola-Olli

Institute for Molecular Medicine Finland

FINLAND

View details

Jari Tiihonen

Karolinska Institutet

SWEDEN

View details

Tapio Paljärvi

Niuvanniemi Hospital

FINLAND

View details

Jaana Suvisaari

Research Professor, Head of Unit

National Institute for Health and Welfare

FINLAND

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Markku Lähteenvuo

Research Interests

Explore related searches

Contact this professor

Articles (20)

Psychopathic Traits Associate With Later Schizophrenia

Sleep and schizophrenia polygenic scores in non-affective and affective psychotic disorders

Cause-specific mortality in treatment-resistant major depression: Population-based cohort study

Criminal Behavior in Early Onset Neurodegenerative Diseases

Dosing levels of antipsychotics and mood stabilizers in bipolar disorder: A Nationwide cohort study on relapse risk and treatment safety

Influence of CYP2D6 phenotype on adherence, adverse effects, and attitudes in aripiprazole and risperidone users

Machine learning-based mortality risk assessment in first-episode bipolar disorder: a transdiagnostic external validation study

Repurposing Semaglutide and Liraglutide for Alcohol Use Disorder

miRNA profiling of hiPSC-derived neurons from monozygotic twins discordant for schizophrenia

General medical comorbidities in psychotic disorders in the Finnish SUPER study

Cohort profile: SUPER-Finland – the Finnish study for hereditary mechanisms of psychotic disorders

Mortality in psychotic depression: 18-year follow-up study

Real-world effectiveness of pharmacological treatments for bipolar disorder: register-based national cohort study

Substance Use and Sleep Problems in Patients With Psychotic Disorders

Real-world effectiveness of antidepressant use in persons with schizophrenia: within-individual study of 61,889 subjects

Effects of Substance Use and Antisocial Personality on Neuroimaging-Based Machine Learning Prediction of Schizophrenia

Implementation of CYP2D6 copy-number imputation panel and frequency of key pharmacogenetic variants in Finnish individuals with a psychotic disorder

Associations between antipsychotic use, substance use and relapse risk in patients with schizophrenia: real-world evidence from two national cohorts

Comparative effectiveness of mood stabilizers and antipsychotics in the prevention of hospitalization after lithium discontinuation in bipolar disorder

Primary Nonadherence to Antipsychotic Treatment Among Persons with Schizophrenia

Collaborators (11)

Minna Holm

Seena Fazel

Mari Kaunisto

Erkki Isometsä

Annamari Tuulio-Henriksson

Aarno Palotie

Kimmo Suokas

Ari Ahola-Olli

Jari Tiihonen

Tapio Paljärvi

Jaana Suvisaari

Make your next move.